MAnufacturing process for Cold-chain Independent VIrosome-based VAccines

Project Information

MACIVIVA

Grant agreement ID: 646122

DOI

10.3030/646122

Project closed

EC signature date 13 March 2015

Start date 4 May 2015

End date 3 November 2018

Funded under

• INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies

Total cost

€ 8 438 905,63

EU contribution

€ 5 338 886,88

Coordinated by

MYMETICS BV
Netherlands

• Making vaccines immune to heat
  EN